AU2753700A - Use of hydroxyurea and a reverse transcriptase inhibitor to induce autovaccination by autologous hiv - Google Patents

Use of hydroxyurea and a reverse transcriptase inhibitor to induce autovaccination by autologous hiv

Info

Publication number: AU2753700A
Authority: AU; Australia
Prior art keywords: autovaccination; hydroxyurea; induce; reverse transcriptase; transcriptase inhibitor
Prior art date: 1999-02-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU27537/00A

Inventor

Julianna Lisziewicz

Franco Lori

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-03

Filing date

2000-02-02

Publication date

2000-08-25

2000-01-28 Priority claimed from US09/493,769 external-priority patent/US20030095988A1/en

2000-02-02 Application filed by Individual filed Critical Individual

2000-08-25 Publication of AU2753700A publication Critical patent/AU2753700A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Immunology (AREA)
Mycology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU27537/00A 1999-02-03 2000-02-02 Use of hydroxyurea and a reverse transcriptase inhibitor to induce autovaccination by autologous hiv Abandoned AU2753700A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US24375399A	1999-02-03	1999-02-03
US09243753		1999-02-03
US09/493,769 US20030095988A1 (en)	2000-01-28	2000-01-28	Method of inducing autovaccination against HIV infection using structured treatment interruptions
US09493769		2000-01-28
PCT/US2000/002754 WO2000045844A1 (en)	1999-02-03	2000-02-02	Use of hydroxyurea and a reverse transcriptase inhibitor to induce autovaccination by autologous hiv

Publications (1)

Publication Number	Publication Date
AU2753700A true AU2753700A (en)	2000-08-25

Family

ID=26936052

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU27537/00A Abandoned AU2753700A (en)	1999-02-03	2000-02-02	Use of hydroxyurea and a reverse transcriptase inhibitor to induce autovaccination by autologous hiv

Country Status (3)

Country	Link
EP (1)	EP1146904A4 (en)
AU (1)	AU2753700A (en)
WO (1)	WO2000045844A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030095988A1 (en) *	2000-01-28	2003-05-22	Julianna Lisziewicz	Method of inducing autovaccination against HIV infection using structured treatment interruptions
FR2821556B1 (en) *	2001-03-02	2003-04-25	Aventis Pasteur	USE OF LIPOPEPTIDES FOR IMMUNOTHERAPY OF HIV + SUBJECTS
US20030044428A1 (en) *	2001-01-26	2003-03-06	Moss Ronald B.	Method for treating an HIV-infected individual by combining immunization with structured interruption of anti-retroviral treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5413999A (en) *	1991-11-08	1995-05-09	Merck & Co., Inc.	HIV protease inhibitors useful for the treatment of AIDS
JP4117901B2 (en) *	1993-05-21	2008-07-16	アメリカ合衆国	A novel method of inhibiting reverse transcriptase-dependent virus replication by using inhibitors of deoxynucleotide synthesis
US6093702A (en) *	1993-12-20	2000-07-25	The United States Of America As Represented By The Department Of Health And Human Services	Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
US5521161A (en) *	1993-12-20	1996-05-28	Compagnie De Developpment Aguettant S.A.	Method of treating HIV in humans by administration of ddI and hydroxycarbamide
US6114312A (en) *	1997-03-07	2000-09-05	Research Institute For Genetic And Human Therapy (R.I.G.H.T.)	Method of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitor

2000
- 2000-02-02 EP EP00905949A patent/EP1146904A4/en not_active Withdrawn
- 2000-02-02 AU AU27537/00A patent/AU2753700A/en not_active Abandoned
- 2000-02-02 WO PCT/US2000/002754 patent/WO2000045844A1/en not_active Ceased

Also Published As

Publication number	Publication date
EP1146904A1 (en)	2001-10-24
WO2000045844A1 (en)	2000-08-10
EP1146904A4 (en)	2004-09-15

Similar Documents

Publication	Publication Date	Title
SG80631A1 (en)	2001-05-22	Inhibitors of hiv reverse transcriptase
SK5342002A3 (en)	2003-04-01	Tricyclic compounds useful as HIV reverse transcriptase inhibitors
AU2436792A (en)	1993-03-16	Quinazoline derivatives as inhibitors of hiv reverse transcriptase
AU2002305375A1 (en)	2002-11-18	Peer to peer collaboration for supply chain execution and management
AU2002253405A1 (en)	2002-08-28	Adapting a game state to be compatible with a new version of a game
AUPR516901A0 (en)	2001-06-14	Improvements to a single use syringe
NO953308D0 (en)	1995-08-23	Inhibitors of HIV reverse transcriptase
AU2001243347A1 (en)	2001-09-12	Hydratable form of keratin for use as a soil amendment
AU2001247434A1 (en)	2001-09-24	Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof
AU2001278955A1 (en)	2002-06-18	Use of alpha-keratose as a blood plasma expander
AU2753700A (en)	2000-08-25	Use of hydroxyurea and a reverse transcriptase inhibitor to induce autovaccination by autologous hiv
AU2001270193A1 (en)	2002-04-08	Pharmaceutical composition containing psyllium fiber and a lipase inhibitor
AU4220493A (en)	1993-11-29	New quinazolines as inhibitors of hiv reverse transcriptase
AU2001228327A1 (en)	2001-08-14	Crystallisation of a glp-1 analogue
AU2002213882A1 (en)	2002-03-22	Attenuated hiv strains and use thereof
AU2002215280A1 (en)	2002-06-03	A construction and a method to be used in a carrier rocket or a satellit
AU2001289295A1 (en)	2001-10-15	Universal input to dc output conversion circuitry
AU2001278155A1 (en)	2002-02-18	Fermentation and purification of mycolactones
AU2001249161A1 (en)	2001-10-03	Asymmetric synthesis of quinazolin-2-ones useful as hiv reverse transcriptase inhibitors
AU6583900A (en)	2001-03-13	Easy to remove adhesive sheets
AU4698399A (en)	2000-01-17	1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
AU2143292A (en)	1992-12-30	Peptidomimetic inhibitors of hiv gp120 binding to cd4
AU2001247412A1 (en)	2001-09-24	Conversion of hydrocarbon-contaminated particulate soil and/or rock to fertile soil
AU2001233575A1 (en)	2001-09-03	Necklace charm made up of diy pieces
AU2001277199A1 (en)	2002-03-13	Immunosuppression using piceatannol and a calcineurin inhibitor

Legal Events

Date	Code	Title	Description
2001-11-22	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase